Trial intelligence / Profile preview

Ticagrelor in Remote Ischemic Preconditioning Study (TRIP)

NCT04174261Phase 4Completed

Sponsor
Hellenic Society of Interventional Cardiology
Start
Jan 2017
Primary completion
Dec 2017
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in myocardial infarction (MI), sponsored by Hellenic Society of Interventional Cardiology. Started Jan 2017; status: completed.

02

Drugs

ticagrelor
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT04174261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04174261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call